These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1652 related articles for article (PubMed ID: 26921617)

  • 1. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
    Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
    Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
    Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
    Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures.
    Hellwig S; Masuch A; Nestel S; Katzmarski N; Meyer-Luehmann M; Biber K
    Sci Rep; 2015 Sep; 5():14624. PubMed ID: 26416689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Abca7
    Butler CA; Mendoza Arvilla A; Milinkeviciute G; Da Cunha C; Kawauchi S; Rezaie N; Liang HY; Javonillo D; Thach A; Wang S; Collins S; Walker A; Shi KX; Neumann J; Gomez-Arboledas A; Henningfield CM; Hohsfield LA; Mapstone M; Tenner AJ; LaFerla FM; Mortazavi A; MacGregor GR; Green KN
    Alzheimers Dement; 2024 Jul; 20(7):4914-4934. PubMed ID: 38506634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.
    Henningfield CM; Arreola MA; Soni N; Spangenberg EE; Green KN
    Glia; 2022 Feb; 70(2):287-302. PubMed ID: 34643971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhao R; Hu W; Tsai J; Li W; Gan WB
    Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
    Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
    Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.